Stuttgart - Delayed Quote EUR

Amphastar Pharmaceuticals Inc (29A.SG)

Compare
34.66 -0.05 (-0.14%)
As of 8:00:44 AM GMT+1. Market Open.

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

33.4

Severe

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
2SX.SG 2SX.SG,0P0001JZ9A,0 33 -- -- --
INZY Inozyme Pharma, Inc. 33 -- -- --
29A.SG Amphastar Pharmaceuticals Inc. 33 -- -- --
LCLA.MU Kalbe Farma, PT R 33 5 18 11
GU5.BE Guangzhou Baiyun.Pharm.Hldg.CoR 33 4 19 11

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 1/2025
29A.SG
Category Average
1 Low Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers